Across TCGA pan-cancer cohorts, OR7E116P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR7E116P data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR7E116P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E116P expression acts as an unfavorable survival marker, although some lineages such as LUSC and KIRC show a favorable association.
COAD, CHOL, and PCPG are the cancer types where OR7E116P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.